Weekly Skin Scan

This week, we’re highlighting stories about itch. Read about more topics here.

New ways to tackle itch in atopic dermatitis

Traditional and popular treatments aimed at calming the often intense pruritus that accompanies atopic dermatitis might not be optimal therapeutic options, according to a recent review.

Nuogen Pharma: Innovation in the fight against itch

Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.

Pay attention to pain caused by itch in atopic dermatitis

Pain is a distinct and important symptom of atopic dermatitis experienced by almost two thirds of patients, reports a recent study.

Itch may require different treatment approaches

Understanding the pattern of pruritus in various autoimmune connective tissue diseases may help physicians identify different etiologies that will inform different treatment targets to alleviate the symptom, according to researchers who examined pruritus relative to disease.

Pathogenesis of atopic dermatitis

In this Dermatology Times^® podcast, Emma Guttman, MD, PhD, discusses familial predisposition for atopic dermatitis, hypothesized links between the disease and the Atopic March, prevention of comorbidities through treatment, and variables of adult onset.

Listen to the podcast now.

Connect with us on Twitter and Facebook for daily updates.

From our Latest Issue

A basis for standardizing care for patients with atopic dermatitis

Psoriasis guidelines offer management pearls for pediatric patients

New concepts in cosmeceuticals: Body rhythm moisturizers